{"id":18,"date":"2025-11-19T23:36:58","date_gmt":"2025-11-19T22:36:58","guid":{"rendered":"https:\/\/fhucare.com\/axis-4-new-eductation\/"},"modified":"2026-03-09T11:51:59","modified_gmt":"2026-03-09T10:51:59","slug":"new-education","status":"publish","type":"page","link":"https:\/\/fhucare.com\/fr\/research-axes\/new-education\/","title":{"rendered":"New Education – TEACH"},"content":{"rendered":"\n
\n
\n

Leaders<\/strong><\/em><\/h2>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/a>
Samuel Bitoun<\/a><\/strong><\/figcaption><\/figure>\n\n\n\n
\"\"<\/a>
Olivier Lambotte<\/a><\/strong><\/figcaption><\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n

Task 1<\/strong><\/em><\/p>\n<\/div>\n\n\n\n

\n

Transdisciplinary Immunology Journal Club #TIJC<\/mark><\/strong><\/em><\/strong><\/em><\/strong><\/em><\/h2>\n\n\n\n

We have created and launched a new Club<\/strong> titled Transdisciplinary Immunology Journal Club <\/strong>(TIJC), which brings together doctors<\/strong>, researchers <\/strong>and students passionate <\/strong>about immunology<\/strong>. <\/mark><\/p>\n\n\n\n

We explore key articles<\/strong> relevant to various medical specialties<\/strong> and discuss the latest advances in immunopathology. <\/p>\n\n\n\n

It is led by Samuel Bitoun<\/a><\/strong> and Fran\u00e7ois-Xavier Danlos<\/a><\/strong>. <\/p>\n\n\n\n

All sessions are available for replay.<\/p>\n\n\n\n

\n
Watch TIJC Replays <\/a><\/div>\n\n\n\n
Full Program of the <\/mark>Journal Club TIJC<\/mark><\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n

Task 2<\/strong><\/em><\/p>\n<\/div>\n\n\n\n

\n

International Summer School (theoretical and<\/strong> practical courses) for CAR-T cells, CAAR-T cells and BiTE management in autoimmune diseases, solid cancer and hematological malignancies<\/strong><\/mark><\/em><\/strong><\/em><\/h2>\n\n\n\n

These international Summer Schools<\/strong> and courses target medical students, residents, fellows, doctors, nurses, taking care of patients with autoimmune diseases <\/strong>(field of rheumatology, internal medicine, neurology, gastroenterology, nephrology…), solid cancers<\/strong> and hematological <\/strong>malignancies.<\/p>\n\n\n\n

\n
Read more about this Summer School<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n

Task 3<\/strong><\/em><\/p>\n<\/div>\n\n\n\n

\n

Development of the existing E-learning SPOC on relations between autoimmunity and cancer<\/mark><\/strong><\/em><\/h2>\n\n\n\n

The Management of Immune Related Adverse Events of Cancer Immunotherapy<\/em> (MIRACIP<\/a><\/strong>) SPOC, part of the European University Alliance for Global Health (EUGLOH<\/a><\/strong>), is led by Olivier Lambotte<\/a> (Universit\u00e9 Paris-Saclay)<\/strong> and Samuel Bitoun<\/a><\/strong>. This international online course has already gathered over +100 participants<\/strong> every edition.<\/p>\n\n\n\n

Immunotherapy has revolutionized oncology through immune checkpoint inhibitors (ICIs)<\/strong>, but up to 70% of treated patients<\/strong> experience immune-related adverse events (irAEs<\/strong>). These toxicities, distinct from those of traditional therapies, demand rapid, multidisciplinary management and a strong understanding of their mechanisms.
MIRACIPS<\/strong> responds to this educational need through a 25-hour <\/strong>program (in English, subtitled FR) including short expert videos, quizzes, and discussion forums.<\/p>\n\n\n\n

Upon completion, participants receive a <\/strong>University Certificate (3 ECTS)<\/strong>.<\/p>\n\n\n\n

Modules:<\/strong><\/p>\n\n\n\n

It is led by Samuel Bitoun<\/a><\/strong> and Camille Bigenwald<\/a><\/strong>.<\/p>\n\n\n\n